Professor Jonathan Craig-President, Research Portfolio
Professor Jonathan C. Craig MBChB, DCH, MMed(Clin Epi), FRACP, PhD holds a Personal Chair in Clinical Epidemiology at the University of Sydney, and is a Senior Staff Specialist at the Children’s Hospital at Westmead in the Department of Paediatric Nephrology. He is Associate Dean of Research in the Faculty of Medicine at the University of Sydney. He is an internationally recognised clinician-scientist with expertise in epidemiology, focussed on improving the health of people with chronic kidney disease, especially children and Indigenous people. His awards include International Distinguished Medal of the National (US) Kidney Foundation (2010), TJ Neale Award for Outstanding Contribution to Nephrological Science, and Honorary Membership of the Italian Society of Nephrology (2004). He is a past Chair of the Steering Group of the Cochrane Collaboration, is a past member of the Expert Advisory Group for the Structural Review of NHMRC’s Grant Program, and non-executive board member of Kidney Health Australia. He is a member of the NHMRC Advisory Group on the Synthesis and Translation of Research Evidence, a member of the Pharmaceutical Benefits Advisory Committee, a member of the Medicare Services Advisory Committee, a member of the International Advisory Panel for Singapore’s Agency for Care Effectiveness, and member of the WHO expert review panel for global strategy and plan of action on public health, innovation and intellectual property.He has served on the editorial boards of many national and international journals including the Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Medical Journal of Australia, Nephrology and is the Coordinating Editor of the Cochrane Kidney and Transplant Group. He is a Chief Investigator of the BEAT-CKD Program and provides oversight to the KHA-CARI guidelines.
A/Prof Nigel Toussaint- President Elect, Dialysis Portfolio
Nigel Toussaint, MBBS, FRACP, PhD, is the Deputy Director of Nephrology at Melbourne Health and a Clinical Associate Professor within the Department of Medicine at the University of Melbourne. He completed his nephrology training in Melbourne in 2005 and completed his PhD studies at Monash University in 2009 undertaking clinical research in the area of vascular calcification and cardiovascular risk in patients with chronic kidney disease. He has also completed a Graduate Diploma in Clinical Epidemiology, and an NHMRC National Institute of Clinical Studies Fellowship in the area of implementation research. A/Prof Toussaint is a nephrologist at The Royal Melbourne Hospital and his current research involves clinical epidemiology and clinical trials as well as translational research in the areas of CKD-MBD biomarkers, vascular calcification and renal osteodystrophy. He is also on the Working Group for the international KDIGO CKD-MBD Clinical Guidelines.
Dr Germaine Wong - Honorary Executive Officer, Gender Equity and Education Portfolio
Germaine Wong is the current HEO of the ANZSN and is responsible for the Education and Gender Equity/Diversity portfolio within Council. She is a transplant nephrologist at Westmead Hospital, in Sydney, and an NHMRC Career Development Fellow at the University of Sydney. Her main areas of research interest are cancer epidemiology, diagnostic test evaluations, decision and simulation modelling, and other important aspects of outcomes research in nephrology and transplantation such as utility-based quality of life measures, transplantation outcomes in young adults, cancer and cardiovascular disease after transplantation; and areas in organ donation, wait-listing and organ allocation.
Dr Girish Talaulikar- Treasurer, RACP Portfolio
A/Prof Girish Talaulikar is the Director of the ACT/SouthernNSWLHD Renal Network. He has formal qualifications in Clinical Epidemiology and Healthcare Management. Girish has experience in creating clinical and social networks to improve chronic healthcare
delivery incorporating electronic information transfer to support care delivery and clinical research.His area of interest includes unwarranted variation and value in healthcare, health economics and vascular access management.
He is presently completing a Fellowship of the College of Medical Administrators and spends his spare time playing a game of tennis and reading about evidence based economics and its impact on poverty alleviation in the developing world.
A/Prof Talaulikar is Treasurer of ANZSN and represents the Council on the Advanced Trainee Committee and the RACP Council.
Associate Professor David Mudge MBBS, MD, FRACP, FASN
David Mudge is a consultant nephrologist at Princess Alexandra Hospital and visiting nephrologist at Redland Hospital, as well as a clinical researcher with the University of Queensland Centre for Kidney Disease Research His clinical research interests include the thrombotic microangiopathies, iron supplementation in chronic kidney disease, chronic kidney disease and antiviral medications, and the use of honey to prevent infections in dialysis patients. He has published over 140 peer-reviewed papers and abstracts with over 2000 citations.He is currently a member of the International Society of Nephrology’s Meetings Committee, the KHA-CARI Guidelines Steering Committee, and an Editor for the Cochrane Kidney and Transplant Group.
Dr Katherine Barraclough - International and Environmental Portfolios
Katherine Barraclough is a Consultant Nephrologist at the Royal Melbourne Hospital in Melbourne. She graduated from Monash University in 2001 and was admitted as a Fellow of the Royal Australian College of Physicians in 2008. Her nephrology training included 6 months at The Alfred Hospital (Melbourne), 12 months at Vancouver General Hospital (Vancouver), 6 months at the All India Institute of Medical Sciences (New Delhi) and 12 months at the Princess Alexandra Hospital (Brisbane). She subsequently completed a PhD through the University of Queensland (2012) undertaking clinical research examining pharmacogenetic, pharmaocokinetic and pharmaocdynamic monitoring of immunosuppressive therapy in adult kidney transplant recipients. Her primary research interests include individualization of immunosuppression in kidney transplantation, Indigenous Australian renal health and disease and environmental sustainability within the health care system. She is current Chair of the Victorian Nephrology Environmental Sustainability Special Interest Group and sits on the Victorian State and National Biodiversity committees for Doctors for the Environment, Australia. Katherine joined the ANZSN Council in 2014. She holds the International Affairs portfolio and chairs the ANZSN Green Nephrology Action Team.
Dr Murray Leikis - New Zealand Portfolio
Murray Leikis is a renal physician from Wellington Hospital, New Zealand. After training in Wellington and the Royal Melbourne Hospital he returned to Wellington in 2006. He is currently Chair of the New Zealand Chapter of the ANZSN, joining the council in 2014 and sits on the National Renal advisory Board in New Zealand. He is Clinical Leader of the Wellington Renal Service with clinical work covering all aspects of renal care.
Dr Ross Francis - Transplantation Portfolio
Ross Francis is a Consultant Nephrologist and Transplant Physician at Princess Alexandra Hospital in Brisbane. His clinical interests range from translation of novel treatments for immunological kidney disease and transplantation (including biological and cellular therapies) to improving transition care for young adults with kidney disease. Ross is responsible for the transplantation portfolio within ANZSN council and represent ANZSN on the Renal Transplant Advisory Committee (RTAC).
Dr Jaqui Hughes- Indigenous Health Equity Portfolio
Dr Jaqui Hughes BMed FRACP PhD is a nephrologist at Royal Darwin Hospital and NHMRC Early Career Research Fellow at Menzies School of Health Research in Darwin. Her PhD study focussed on detailed assessments of body composition of Aboriginal and Torres Strait Islander peoples among adults with or at risk of chronic kidney disease. Her most important research contribution includes validating the accuracy of estimated equations of kidney function and identifying biomedical factors associated with rapid progression of chronic kidney disease as part of The eGFR Study. At the Royal Darwin Hospital, she provides care for people with chronic and end stage kidney disease and supports cultural security and information priorities of patients. She is the clinical research liaison for the Joint NT Renal Services-Menzies research program. In 2017 she was elected to Council for the Australian and New Zealand Society of Nephrology (2017), and leads the Indigenous Kidney Health Equity portfolio. She was appointed (2016) Australian co-lead of the Kidney Health Australia –Caring for Australasians with Renal Impairment (KHA-CARI) Inaugural guideline on the management of chronic kidney disease in Aboriginal and Torres Strait Islander peoples and Maori, and has been Australian co-convenor of Australia and New Zealand Dialysis and Transplantation Registry Indigenous Health Working Group (2014-).
Josh Kausman - Paediatric Portfolio ANZPNA Rep
Dr Joshua Kausman MBBS PhD FRACP is the current chair of the Australia and New Zealand Paediatric Nephrology Association (ANZPNA) and paediatric representative on ANZSN council. He is a consultant nephrologist at the Royal Children’s Hospital in Melbourne, where he is clinical lead in kidney transplantation. He has experience in laboratory based basic science research in immune-mediated kidney disease and clinical research experience as principal investigator in a number of single and multi-centre trials. His main interests in nephrology are in transplantation, immune-mediated kidney disease, HUS and transition. Advocacy for the welfare of children and adolescents with kidney disease is a focus of his work, as part of which he contributes to a variety of working groups and committees. These include chair of the paediatric sub-committee of the Transplantation Society of Australia and New Zealand (TSANZ), Organ and tissue authority Transplant Liaison Reference Group, Renal Transplant Advisory Committee histocompatibility sub-committee, TTP registry steering committee and the AKTN working group on glomerulonephritis.
Maintenance of the exceptional standard of paediatric nephrology services across Australia and New Zealand is another priority as well as assistance in the welfare of the health of children with kidney disease among our less advantaged neighbours. Through ANZPNA activities and the now well-integrated collaborative links with ANZSN a number of exciting projects are planned or underway to provide training for our emerging nephrologists and on the ground support for the Oceania region. This makes it a particularly exciting time to be a member of ANZSN council.
Ms Shaune Noble
Ms Jourdan Pinnell